Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

(2021) Adam Cuker et al.   Blood Advances

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

(2021) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)–Coalition IV trial

(2021) Renato D. Lopes et al.   AMERICAN HEART JOURNAL

Coagulopathy of Coronavirus Disease 2019

(2020) Toshiaki Iba et al.   CRITICAL CARE MEDICINE

Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19

(2020) Alex C. Spyropoulos et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

(2020) Maximilian Ackermann et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

(2020) Hanny Al-Samkari et al.   BLOOD

Post-discharge venous thromboembolism following hospital admission with COVID-19

(2020) Lara N Roberts et al.   BLOOD

Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019

(2020) Lisa K. Moores et al.   CHEST

Randomized Trials Versus Common Sense and Clinical Observation

(2020) Alexander C. Fanaroff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

(2020) Alex C. Spyropoulos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

(2020) Alexandre B. Cavalcanti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis

(2020) Baris Gungor et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

Anticoagulation in COVID-19

(2020) Renato D. Lopes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

(2020) Girish N. Nadkarni et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients

(2020) Baranca Buijsers et al.   EBioMedicine

Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve

(2020) Helio P. Guimarães et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019

(2020) David Jiménez et al.   CHEST

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

(2018) Alex C. Spyropoulos et al.   NEW ENGLAND JOURNAL OF MEDICINE

The stratified win ratio

(2017) Gaohong Dong et al.   Journal of Biopharmaceutical Statistics

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

(2017) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

(2015) S. Kaatz et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

(2011) Roxana Mehran et al.   CIRCULATION

The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities

(2011) S. J. Pocock et al.   EUROPEAN HEART JOURNAL

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE